Product Images Levetiracetam

This text provides instructions for calculating the estimated creatinine clearance rate (CLer) for female patients based on their age, weight, and serum creatinine levels. The formula for CLer is given, along with an adjustment for body surface area. The text may be useful for medical professionals involved in evaluating kidney function in female patients.*

This is a medication guide for Levetiracetam tablets, USP. Each tablet contains 1000 mg of Levetiracetam, USP. The usual dosage should be checked from the package insert. It should be stored between 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container with a child-resistant closure. It is manufactured for Laurus Generics Inc. by VKT Pharma Private Limited, Srikakulam, India - 532 409. If you want to know more about the medicine, you can access the medication guide at the given URL. The batch code details are to be written on the unvarnished area (50 x 20 mm).*

This is a medication description for Levetiracetam tablets, USP, containing 250mg of Levetiracetam each. The usual dosage information is available in the package insert. The tablets must be stored at 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C to 30°C (59°F to 86°F). Pharmacists must dispense the medication in a tight, light-resistant container with a child-resistant closure and provide the accompanying medication guide. Manufactured by VKT Pharma Private Limited in India and distributed by Laurus Generics Inc. in Berkeley Heights, NJ. Batch code details must be written in the unvarnished area.*

This appears to be a table displaying the dosage of placebo and two different dosages of Levetiracetam (1000 mg/day and 3000 mg/day), along with the number of participants in each group (95 for placebo, 97 for 1000 mg/day Levetiracetam, and 101 for 3000 mg/day Levetiracetam). Without additional context, it is unclear what the purpose of this table is or what study it corresponds to.*

This text seems to be describing the results of a study or experiment involving two groups of participants: one group received a placebo treatment (N=104) and the other group received levetiracetam at a dose of 3000 mg/day (N=180). The other information provided includes a series of percentages, possibly related to effectiveness or success rates, but without additional context it is not possible to determine their meaning.*

Levetiracetam is a prescription drug available in tablet form. Each tablet contains 500mg of Levetiracetam, USP. The usual dosage is provided in the package insert. It should be stored between 20°C and 25°C with excursions permitted between 15°C and 30°C. The tablets should be dispensed in a tightly closed, light-resistant container with a child-resistant closure. The medication guide is available with the medication and is necessary for dispensing. The manufacturer of the drug is VKT Pharma Private Limited, Srikakulam, India, and it is manufactured for Laurus Generics Inc. However, the given text doesn't offer any additional useful information.*

This is a prescription drug called Levetiracetam, which comes in tablet form, with each tablet containing 500 mg of Levetiracetam. The recommended storage temperature is between 20 to 25°C. The medication guide is required for each patient and should be provided with the medication. It is manufactured by VKT Pharma Private Limited in India and is distributed by Laurus Generics Inc., based in New Jersey. More information is available on the website listed.*

The text provides percentages of patients treated with placebo (N=51) and Levetiracetam (N=58). There is a statistically significant difference between the two treatments, but it doesn't specify what the treatments are for or what the percentages relate to.*

This is a medication guide for Levetiracetam tablets manufactured by VKT Pharma Private Limited in India. Each tablet contains 750 mg of the medication. It is advised to store the tablets between 20° to 25°C, with excursions permitted between 15° to 30°C. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure and a medication guide must be provided. See the package insert for complete dosage recommendations.*